Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The induction of angiogenesis by bFGF is significantly inhibited by oral treatment of Lenalidomide in a dose-dependent manner
PubMed Central PMCID: PMC3660094
InChiKey: AKIIPHDGVCFVCC-UHFFFAOYSA-N
AZD3463 also exhibited significant therapeutic efficacy on the growth of the NB tumors with WT and F1174L activating mutation ALK in orthotopic xenograft mouse models
Chemical Name: 2-(3-{4-[(1H-indazol-5-yl)amino]quinazolin-2-yl}phenoxy)-N-(propan-2-yl)acetamide
Pralidoxime iodide rumic acid The induction of angiogenesis byPralidoxime iodide is a reactivator of acetylcholinesterase (AChE). Pralidoxime iodide reactivates nerve agent, which inhibits AChE via direct nucleophilic attack by the oxime moiety on the phosphorus center of the bound nerve agent. Pralidoxime iodide is an antidote for organophosphate poisoning. Product information CAS Number: 94 63 3 Molecular Weight: 264. 06 Formula: C7H9IN2O Chemical Name: 2 [(1E) (hydroxyimino)methyl] 1 methylpyridin 1 ium
US$ 82.00
US$ 88.00
US$ 65.00
US$ 167.95
US$ 48.00
US$ 62.00
US$ 72.00
US$ 48.00
US$ 88.00